MarginsXMarginsX
Home › Markets › Health Care › INMD

InMode Ltd. (INMD)

INMD trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$13.15
-0.90% on the day
Market cap
$755.9M
Small cap
Revenue · 2025
$370.5M
-6.2% on 2024
Net income · 2025
$93.8M
25.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 20-F (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1742692/000117891326000377/0001178913-26-000377-index.htm. Net income: SEC 20-F (us-gaap:ProfitLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerINMD on Nasdaq
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryIsrael
IPO year2019
SEC CIK0001742692
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Incorporated inIsrael

Financials · 2025

LineValue
Revenue$370.5M
Net income$93.8M
Operating income$85.4M
Net margin25.3%
Operating margin23.0%
Revenue growth-6.2%
Cash$302.5M
Total assets$766.4M
P/E (computed)8.1×
P/S (computed)2.0×

Warning signs

Cash runway
Cash-flow positive
$302.5M cash at December 31, 2025
Share count, 1 year
-8.9%
2024-12-31 to 2025-12-31 · -23.2% over 3 years
Going-concern doubt
No
20-F filed February 10, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-02-10
Cash and burn$302.5M cash; operating cash flow $21.3M a quarter.Report 2025-12-31
Shares outstanding63,358,750 (2025-12-31); 69,558,670 a year earlier; 82,544,991 three years earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorKesselman & Kesselman C.P.A.s, Tel-Aviv, IsraelPCAOB Form AP 2026-02-24
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
$370.5M$93.8M$85.3M$302.5MNo debt tags$370.5M20-F 2026-02-10
FY 2024
2024-12-31
$394.8M$181.3M$132.7M$155.3MNo debt tags$394.8M20-F 2026-02-10
FY 2023
2023-12-31
$492.0M$197.9M$176.8M$144.4MNo debt tags$492.0M20-F 2026-02-10
FY 2022
2022-12-31
$454.3M$161.5M$181.6M$97.5MNo debt tags$454.3M20-F 2025-02-04
FY 2021
2021-12-31
$357.6M$165.0M$174.9M$68.1MNo debt tags$357.6M20-F 2024-02-13
FY 2020
2020-12-31
$206.1M$75.0M$79.2M$68.9MNo debt tags$206.1M20-F 2023-02-14
FY 2019
2019-12-31
$156.4M$61.1M$62.2M$44.7MNo debt tags$156.4M20-F 2022-02-10
FY 2018
2018-12-31
$100.2M$22.4M$36.9M$24.7MNo debt tags$100.2M20-F 2021-02-10

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42019-08-08
Latest annual report20-F2026-02-10
Latest quarterly / interim6-K2026-11-12

Source: SEC EDGAR submissions feed, 157 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-0.5%
1 month-7.2%
3 months-12.7%
Year to date-9.7%
1 year-7.2%
From 52-week high-20.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
CBLLCeriBell Inc.$26.42+1.07%$1.0B
CNMDCONMED Corporation$49.35-2.45%$1.5B
CVCapsoVision Inc.$6.47+7.30%$346.9M
ELMDElectromed Inc.$23.10-5.02%$188.8M
TMDXTransMedics Group Inc.$92.21+0.91%$3.2B
AXGNAxogen Inc.$55.38-0.98%$3.3B
FOCLEDAP TMS S.A.$3.17-2.39%$149.7M
LIVNLivaNova PLC$92.44+1.23%$5.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier